Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.00 | N/A |
| PEG Ratio (TTM) | 0.52 | N/A |
| P/S Ratio (TTM) | 2.22 | N/A |
| P/B Ratio (TTM) | 1.73 | N/A |
| P/FCF Ratio (TTM) | 11.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.02 | N/A |
| Price to 5YR AVG FCF Ratio | 24.13 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.53% | N/A |
| ROE (TTM) | 6.63% | N/A |
| Net Profit Margin (TTM) | 8.59% | N/A |
| ROIC 5YR AVG | 19.37% | N/A |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 68.09% | 45.02% | 622.02% |
| Revenue | -5.24% | 27.41% | 37.02% |
| Net Income | 67.83% | 45.58% | 640.73% |
| Cash Flow | 19.98% | 349.20% | 449.40% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.08 | N/A |
| Quick Ratio (TTM) | 1.36 | N/A |
| D/E Ratio (TTM) | 0.26 | N/A |
| Interest Coverage (TTM) | 4.11 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.31 | N/A |
| LTL to 5YR AVG FCF | 4.66 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.09% | N/A |